Trial intelligence / Profile preview

Nebivolol vs Metoprolol in Hypertensive Kidney Transplant Patients

NCT01157234Phase 4Completed

Sponsor
University of Florida
Start
Jul 2010
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of nebivolol in hypertension (HTN) (2 arms), sponsored by University of Florida. Primary endpoint: Plasma Nitric Oxide Level Change at 12 months. Started Jul 2010; status: completed.

02

Drugs

nebivolol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01157234.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01157234.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call